Approval · Notice of Compliance 583 · 2002
EPAXAL: Notice of Compliance 583
Issued May 2, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 583
- Date
- May 2, 2002
- Company
- Berna Biotech Ltd.Bern, Bern, Switzerland
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EPAXAL | 02239910 | Cancelled Post Market |
Medicinal ingredients
- HEPATITIS A VACCINE, INACTIVATED 500 UNIT per 0.5ML